
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
You are part of a select group chosen to receive this survey. Your response to this 3- to 5-minute survey is greatly appreciated. Just click on the secure link below or copy and paste into your browser.
In appreciation for taking this survey, all participants are
eligible to receive a $10 Starbucks gift card.






